Thermo Fisher Scientific’s PPD clinical research business wins clinical research company of the year title, receives multiple honors at PharmaTimes competition
WILMINGTON, N.C. (June 16, 2025) – The PPD™ clinical research business of Thermo Fisher Scientific, the world leader in serving science, has been recognized for excellence in clinical research at the 2025 PharmaTimes Clinical Researcher of the Year International competition.
The business was named “Clinical Research Company of the Year” at the competition, held recently in London, achieving its fifth win in the last six years.
Along with this top honor, 19 clinical research professionals from the business were named winners within various team and individual competition categories, taking home eight awards: two gold, four silver and two bronze, and additional colleagues were named finalists. The company won in each category in which the team had finalists, including aspiring and junior clinical research associate, clinical research associate, project manager, startup individual, team leader, clinical research team and startup team.
“We are incredibly proud of our team’s achievements at the PharmaTimes Clinical Researcher of the Year competition,” said Sebastian Pacios, senior vice president and president, clinical research, Thermo Fisher Scientific. “This recognition is a testament to the dedication and expertise of our team members and their commitment to advancing clinical research and supporting customers.”
The Clinical Researcher of the Year competition, hosted by PharmaTimes, consists of a rigorous series of assessments, including a three-stage competition, where participants give presentations before a panel of experienced industry judges. The event was created to provide clinical research professionals an opportunity to benchmark their skills against their peers in a program of competency-based exercises developed through cross-industry collaboration.
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue over $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com.
Media Contact Information: ppdmedia@thermofisher.com